SG10201910006WA - Materials and methods for respiratory disease control in canines - Google Patents

Materials and methods for respiratory disease control in canines

Info

Publication number
SG10201910006WA
SG10201910006WA SG10201910006WA SG10201910006WA SG 10201910006W A SG10201910006W A SG 10201910006WA SG 10201910006W A SG10201910006W A SG 10201910006WA SG 10201910006W A SG10201910006W A SG 10201910006WA
Authority
SG
Singapore
Prior art keywords
methods
respiratory disease
canines
materials
disease control
Prior art date
Application number
Other languages
English (en)
Inventor
Patti Crawford
Paul Gibbs
Edward Dubovi
Ruben Donis
Jacqueline Katz
Alexander Klimov
Nancy Cox
William Castleman
Original Assignee
Univ Florida
Cornell Research Foundation Inc
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida, Cornell Research Foundation Inc, Us Gov Health & Human Serv filed Critical Univ Florida
Publication of SG10201910006WA publication Critical patent/SG10201910006WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG10201910006W 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines SG10201910006WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21

Publications (1)

Publication Number Publication Date
SG10201910006WA true SG10201910006WA (en) 2019-11-28

Family

ID=37215064

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201910006W SG10201910006WA (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines
SG10201406043TA SG10201406043TA (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201406043TA SG10201406043TA (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Country Status (16)

Country Link
EP (3) EP2495326B1 (enrdf_load_stackoverflow)
JP (6) JP2008536526A (enrdf_load_stackoverflow)
KR (3) KR101738940B1 (enrdf_load_stackoverflow)
CN (3) CN101253267A (enrdf_load_stackoverflow)
AU (1) AU2006240038B2 (enrdf_load_stackoverflow)
BR (2) BRPI0610503B1 (enrdf_load_stackoverflow)
CA (1) CA2606429A1 (enrdf_load_stackoverflow)
ES (1) ES2570758T3 (enrdf_load_stackoverflow)
IL (3) IL186710A (enrdf_load_stackoverflow)
MX (3) MX339202B (enrdf_load_stackoverflow)
NO (2) NO345667B1 (enrdf_load_stackoverflow)
NZ (2) NZ562661A (enrdf_load_stackoverflow)
RU (2) RU2449014C2 (enrdf_load_stackoverflow)
SG (2) SG10201910006WA (enrdf_load_stackoverflow)
WO (1) WO2006116082A1 (enrdf_load_stackoverflow)
ZA (1) ZA200708897B (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
RU2449014C2 (ru) * 2005-04-21 2012-04-27 Юниверсити Оф Флорида Рисерч Фаундейшн, Инк. Штамм вируса гриппа а собак (варианты), иммуногенный полипептид, полинуклеотид, кодирующий его, вектор экспрессии полипептида, иммуногенная композиция, содержащая полипептид, и способ индукции иммунного ответа у животного
WO2006121773A2 (en) 2005-05-06 2006-11-16 Gen-Probe Incorporated Compositions and assays to detect influenza virus a and b nucleic acids
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
BRPI0616328A2 (pt) * 2005-10-07 2011-06-14 Pfizer Prod Inc vacinas e mÉtodos para tratar influenza canino
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
NZ627888A (en) * 2005-10-19 2016-03-31 Cornell Res Foundation Inc Materials and methods for respiratory disease control in canines
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2076280B1 (en) * 2006-10-25 2019-07-10 Intervet International BV Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
RU2708447C2 (ru) * 2013-02-07 2019-12-06 Массачусетс Инститьют Оф Текнолоджи Адаптация вируса гриппа н5 к человеку
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
US20180187273A1 (en) * 2015-07-02 2018-07-05 Indevr Inc. Universal Priming Mixture for Amplification of Influenza Viral Gene Segments for Diagnostic Applications
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
CA2182888C (en) * 1994-03-30 2007-08-07 Enzo Paoletti Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
AU762798B2 (en) 1998-11-24 2003-07-03 Pioneer Hi-Bred International, Inc. Root-preferred promoters and their use
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
EP1317559B1 (en) * 2000-04-28 2009-01-07 St. Jude Children's Research Hospital Dna transfection system for the generation of infectious negative strand rna virus
EP1292614A2 (en) * 2000-06-23 2003-03-19 American Cyanamid Company Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
EP1980268A2 (en) * 2002-04-12 2008-10-15 Ilaria Capua Vaccination methods against avian influenza virus
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
WO2004028471A2 (en) * 2002-09-28 2004-04-08 Massachusetts Institute Of Technology Influenza therapeutic
AU2003294533A1 (en) * 2002-12-19 2004-07-14 Universite Laval Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
EP1623015A4 (en) * 2003-05-15 2007-10-10 Univ Oklahoma State HA1 OF THE EQUINE-2 INFLUENZAVIRUS EXPRESSIVE DNA VACCINE
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
RU2449014C2 (ru) * 2005-04-21 2012-04-27 Юниверсити Оф Флорида Рисерч Фаундейшн, Инк. Штамм вируса гриппа а собак (варианты), иммуногенный полипептид, полинуклеотид, кодирующий его, вектор экспрессии полипептида, иммуногенная композиция, содержащая полипептид, и способ индукции иммунного ответа у животного
BRPI0616328A2 (pt) * 2005-10-07 2011-06-14 Pfizer Prod Inc vacinas e mÉtodos para tratar influenza canino
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
NZ627888A (en) * 2005-10-19 2016-03-31 Cornell Res Foundation Inc Materials and methods for respiratory disease control in canines
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Also Published As

Publication number Publication date
EP2495326A3 (en) 2013-08-28
IL186710A0 (en) 2008-02-09
ES2570758T3 (es) 2016-05-20
EP1871885B8 (en) 2017-08-02
KR101738940B1 (ko) 2017-06-08
NO345667B1 (no) 2021-06-07
CN107099512A (zh) 2017-08-29
MX2018010571A (es) 2022-01-25
KR20150082628A (ko) 2015-07-15
IL208707A0 (en) 2010-12-30
NO20180601A1 (no) 2008-01-21
KR20080039836A (ko) 2008-05-07
NO342494B1 (no) 2018-06-04
JP2013031440A (ja) 2013-02-14
BRPI0610503B1 (pt) 2022-05-31
SG10201406043TA (en) 2014-11-27
CN103451158A (zh) 2013-12-18
JP2024043541A (ja) 2024-03-29
NO20075961L (no) 2008-01-21
EP2489739A2 (en) 2012-08-22
JP2018050636A (ja) 2018-04-05
RU2711791C2 (ru) 2020-01-22
HK1111729A1 (zh) 2008-08-15
EP1871885A1 (en) 2008-01-02
CN103451158B (zh) 2018-11-23
JP2020031658A (ja) 2020-03-05
KR101474011B1 (ko) 2014-12-23
EP2489739B1 (en) 2019-11-20
RU2007143041A (ru) 2009-05-27
JP6301855B2 (ja) 2018-03-28
AU2006240038B2 (en) 2012-07-05
JP2008536526A (ja) 2008-09-11
EP1871885A4 (en) 2009-09-16
RU2011153597A (ru) 2013-07-10
IL249236A0 (en) 2017-01-31
AU2006240038A1 (en) 2006-11-02
NZ583564A (en) 2011-09-30
EP2495326A2 (en) 2012-09-05
JP6042131B2 (ja) 2016-12-14
KR101738937B1 (ko) 2017-05-23
NZ562661A (en) 2010-04-30
IL186710A (en) 2017-09-28
KR20140091770A (ko) 2014-07-22
CN101253267A (zh) 2008-08-27
WO2006116082A1 (en) 2006-11-02
RU2020100038A (ru) 2021-07-09
BR122018012345B1 (pt) 2021-10-26
EP2489739A3 (en) 2013-08-28
MX358750B (es) 2018-08-31
EP2495326B1 (en) 2019-11-20
RU2449014C2 (ru) 2012-04-27
CA2606429A1 (en) 2006-11-02
JP6663416B2 (ja) 2020-03-11
IL208707B (en) 2020-01-30
MX339202B (es) 2016-05-13
BRPI0610503A2 (pt) 2010-06-29
IL249236B (en) 2021-07-29
JP2015144604A (ja) 2015-08-13
EP1871885B1 (en) 2016-02-17
ZA200708897B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
SG10201910006WA (en) Materials and methods for respiratory disease control in canines
MX341842B (es) Virus de la influenza capaces de infectar canidos y usos de los mismos.
WO2008121329A3 (en) Turkey herpesvirus vectored recombinant containing avian influenza genes
MY143262A (en) Roller clutch
SG153829A1 (en) Identifying virally infected and vaccinated organisms
NO20054608L (no) Influensavirusvaksine
WO2007017759A3 (en) Creating poultry and other animals resistant to viral disease
DE602006020300D1 (de) Immunologische verwendungen von immunmodulatorischen verbindungen für einen impfstoff und therapie gegen infektionskrankheiten
SG156652A1 (en) Yeast-based therapeutic for chronic hepatitis c infection
EP2078083A4 (en) NEW CANINE INFLUENZA VIRUS AND CORRESPONDING VACCINE
EP2023952A4 (en) INDUCTION OF IMMUNE REACTIONS TO THE INFLUENZA AVIRUSES USING POLYPEPITD AND NUCLEIC ACID COMPOSITIONS
EP2177535A4 (en) ANTIBODIES WITH HEMMETAL EFFECT ON INFECTIONS WITH HEPATITIS C VIRUS (HCV) AND ITS USE
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
MA34541B1 (fr) Compositions d'anticorps et procédés d'utilisation
Bichaud et al. Isolation, full genomic characterization and neutralization-based human seroprevalence of Medjerda Valley virus, a novel sandfly-borne phlebovirus belonging to the Salehabad virus complex in northern Tunisia
EP2443260A4 (en) VIRAL ANALYSIS
ATE547116T1 (de) Kombinationsimpfstoff
EP1963358A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH THE EPSTEIN-BARR-VIRUS
DE60305884D1 (de) Igg3 immunogloblin als schutzsmarker gegen viren infektiösen krankheiten und seine verwendungen
DK1973931T3 (da) Hønsevirusvaccine og -diagnosticering
WO2008054464A3 (en) Broad spectrum immune and antiviral gene modulation by oral interferon
WO2012089742A3 (en) IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
ATE544856T1 (de) Peptid- und nukleotidsequenzen von anisakis spp. und ihre verwendung
BR112015002371A2 (pt) estirpes mutantes e usos do mesmo de neospora
WO2007062795A3 (de) Bakterieller impfstoff gegen bakterielle infektionserreger für die anwendung bei tieren